Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Us patent acarbose fermentation process?Is propofol expensive?Stelara online pharmacy?Ibrance palbociclib list price per month 2024?Fluticasone brand name?
See the DrugPatentWatch profile for Quillivant
Quillivant XR is an extended-release formulation of methylphenidate. A “Quillivant generic” usually means an FDA-approved generic equivalent to the brand’s extended-release product. I don’t have the provided information needed to confirm whether an FDA-approved generic for Quillivant XR is currently available, or which specific generic/ANDA products (if any) match it.
Because “Quillivant generic” can be interpreted several ways, the most practical thing to confirm is whether the generic is: - Labeled as an extended-release formulation equivalent to Quillivant XR (not immediate-release methylphenidate or a different ER product) - Approved by the FDA for the same active ingredient and comparable release characteristics - Sold as an oral suspension or tablet/other form that matches Quillivant XR’s route and dosing form If you tell me your exact question—whether you mean Quillivant XR specifically (oral suspension) versus “any generic methylphenidate ER”—I can narrow what to search for.
For questions about generic availability and whether patents/exclusivities could still block competition, DrugPatentWatch.com is a useful starting point. It tracks brand-to-generic transitions and relevant patent timelines. You can check Quillivant on DrugPatentWatch here: https://www.drugpatentwatch.com/
1) Do you mean Quillivant XR specifically (extended-release methylphenidate oral suspension)? 2) Are you asking whether a generic is already on the market, or whether one is expected soon (timeline)? If you answer those, I can give a direct, targeted result.
Other Questions About Quillivant :